Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.44 +3.45 (+31.35%)
As of: Sep 29, 2026 · 3:59 PM EDT

Iovance Biotherapeutics (IOVA) Net Equity Issued and Repurchased (2010 - 2026)

Updated

Iovance Biotherapeutics' Net Equity Issued and Repurchased came in at $49.57 million for Q2 2026, up 279.4% from $13.07 million a year earlier but down 49.7% from the prior quarter.

Analysis

Iovance Biotherapeutics (IOVA) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Iovance Biotherapeutics reported Net Equity Issued and Repurchased of $292.38 million, up 39.5% year-over-year; for FY2025, it came in at $306.31 million, down 22.9% from FY2024.

  • Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -11.6% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $397.3 million in FY2024 (-14.2%), $463.28 million in FY2023 (+144.5%), $189.5 million in FY2022 (-6.7%) and $203.16 million in FY2021 (-64.2%).
  • The five-year range for quarterly Net Equity Issued and Repurchased is $1,000 (Q3 2021) to $260.1 million (Q1 2023).
  • Year-over-year, Net Equity Issued and Repurchased increased in two of the last six quarters, with growth averaging 23.2%.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q2 2026 (growth of 279.4%), and the weakest in Q4 2023 (a decline of 100.0%).
  • Business Quant data shows IOVA's Net Equity Issued and Repurchased at $98.51 million (Q1 2026), $55.78 million (Q4 2025) and $88.52 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 6.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 9.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 47.70 Mn
10 Iovance Biotherapeutics 4.98 Bn 3.77 Bn 55.72 Mn 49.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 49.57 Mn
Mar 31, 2026 98.51 Mn
Dec 31, 2025 55.78 Mn
Sep 30, 2025 88.52 Mn
Jun 30, 2025 13.07 Mn
Mar 31, 2025 148.94 Mn
Sep 30, 2024 47.52 Mn
Jun 30, 2024 151.87 Mn
Mar 31, 2024 197.91 Mn
Dec 31, 2023 1,000.00
Sep 30, 2023 203.18 Mn
Mar 31, 2023 260.10 Mn
Dec 31, 2022 187.86 Mn
Sep 30, 2022 225,000.00
Mar 31, 2022 1.42 Mn
Sep 30, 2021 1,000.00
Jun 30, 2021 160.27 Mn
Mar 31, 2021 42.89 Mn
Mar 31, 2020 3.95 Mn
Dec 31, 2019 2.21 Mn
API Access

Iovance Biotherapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IOVA&period=max&api_key=YOUR_API_KEY